14: Engineering Better Cancer Outcomes
from Future Human
Cancer research is at an inflection point. While the disease is poised to overtake heart disease as the leading cause of death this century, massive strides are being made. Indeed, the US saw a 26% reduction in the cancer death rate from 1991-2015. Dr. Benjamin Ebert – a Professor of Medicine at Harvard Medical School and Chair of Medical Oncology at the Dana-Farber Cancer Institute, among many other vaunted positions – recently delivered a Shannon Luminary Lecture where he laid out the current state of play with research, and how the quest to study pre-malignant patients has given rise to new insights that stretch beyond cancer prevention. Listen in as he discusses his findings with Nokia Bell Labs President and Nokia CTO Marcus Weldon. Future Human is a presentation of Nokia Bell Labs, produced by Audiation.fm.
Embed this episode
No transcript yet.